Category: PRESS RELEASES

April 2016

Enterome to participate at the FBR Healthcare Series Conference and the Guggenheim Securities Microbiome Day in New York

January 2016

Enterome announces collaboration with Johnson & Johnson Innovation focused on the discovery of novel targets and therapeutics for Crohn’s disease

January 2016

Takeda and Enterome enter strategic drug discovery collaboration focused on Microbiome Targets Across Multiple Gastrointestinal Disorders

October 2015

Georges Gemayel Appointed Non-executive Chairman of Enterome

January 2015

Clinica Medtech Intelligence

November 2014

Enterome enters into a microbiome-based development collaboration with AbbVie in Crohn’s disease

June 2014

Enterome and Mayo Clinic Enter Collaboration to Develop and Commercialize Microbiome-based Diagnostic Tools for Nutritional Interventions

June 2014

Synthetic Biologics and Enterome Bioscience Collaborate on Microbiome Research to Support Synthetic Biologics’ C. difficile Program

May 2014

Enterome Raises €10 million in Series B Fund Raising